Xiaoping Wu
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Liver physiology and pathology 4
- Liver Disease and Transplantation 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Coronary Artery Anomalies 1
- Inhalation and Respiratory Drug Delivery 1
- Vasculitis and related conditions 1
- Co-authors
- Ruby L.C. Hoo (3 shared papers)Jingjing Li (2 shared papers)Qinglong Guo (1 shared paper)Na Lu (1 shared paper)Jing Yao (1 shared paper)Qi-Dong You (1 shared paper)Li Zhao (1 shared paper)Yi Zhang (1 shared paper)
- Journals
- Thorax (1 paper)DNA and Cell Biology (1 paper)Archives of Pharmacal Research (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)Advanced Science (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoping Wu
26 papers receiving 703 citations
Xiaoping Wu's Hit Papers
Peers
Comparison fields: 5 of 85
- Pulmonary and Respiratory Medicine 334
- Hepatology 58
- Speech and Hearing 43
- Pathology and Forensic Medicine 65
- Physiology 90
Countries citing papers authored by Xiaoping Wu
This map shows the geographic impact of Xiaoping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wu more than expected).
Fields of papers citing papers by Xiaoping Wu
This network shows the impact of papers produced by Xiaoping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wu. The network helps show where Xiaoping Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study Hit paper breakdown → | 2022 | 156 |
| 2 | 2018 | 124 | |
| 3 | 2021 | 87 | |
| 4 | 2014 | 68 | |
| 5 | 2021 | 56 | |
| 6 | 2012 | 43 | |
| 7 | 2019 | 34 | |
| 8 | 2012 | 26 | |
| 9 | 2021 | 17 | |
| 10 | 2022 | 16 | |
| 11 | 2017 | 14 | |
| 12 | 2014 | 14 | |
| 13 | A novel antibody AA98 V(H)/L directed against CD146 efficiently inhibits angiogenesis. | 2008 | 14 |
| 14 | 2020 | 13 | |
| 15 | 2024 | 13 | |
| 16 | 2014 | 5 | |
| 17 | 2025 | 5 | |
| 18 | 2015 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2017 | 2 |
About Xiaoping Wu
Xiaoping Wu is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Epidemiology, Speech and Hearing and Geriatrics and Gerontology, having authored 30 papers that have together received 718 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Liver physiology and pathology (4 papers), Liver Disease and Transplantation (3 papers), Dysphagia Assessment and Management (2 papers), Coronary Artery Anomalies (1 paper), Inhalation and Respiratory Drug Delivery (1 paper) and Vasculitis and related conditions (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (334 citations), Hepatology (58 citations), Speech and Hearing (43 citations), Pathology and Forensic Medicine (65 citations) and Physiology (90 citations). Xiaoping Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ruby L.C. Hoo, Jingjing Li, Qinglong Guo, Na Lu, Jing Yao, Qi-Dong You, Li Zhao, Yi Zhang, Yue Zhao and Lai Yee Cheong. Their work appears in journals such as Thorax, DNA and Cell Biology, Archives of Pharmacal Research, American Journal of Respiratory and Critical Care Medicine and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.